Jiang Wenbin 13D and 13G filings for Cytek Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:07 pm Sale | 2023-12-31 | 13G | Cytek Biosciences, Inc. CTKB | Jiang Wenbin | 5,702,130 4.300% | -2,318,353 (-28.91%) | Filing |
| 2022-02-14 2:04 pm Purchase | 2021-12-31 | 13G | Cytek Biosciences, Inc. CTKB | Jiang Wenbin | 8,020,483 5.990% | 8,020,483 (New Position) | Filing |